Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study ; volume:26 ; number:1 ; day:12 ; month:11 ; year:2024 ; pages:1-13 ; date:12.2024
Arthritis Research & Therapy ; 26, Heft 1 (12.11.2024), 1-13, 12.2024

Urheber
Baraliakos, Xenofon
Heijde, Désirée van der
Sieper, Joachim
Inman, Robert Davies
Kameda, Hideto
Maksymowych, Walter Peter
Lagunes-Galindo, Ivan
Bu, Xianwei
Wung, Peter
Kato, Koji
Shmagel, Anna
Deodhar, Atul
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13075-024-03412-8
URN
urn:nbn:de:101:1-2501292105417.633283642823
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:33 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Baraliakos, Xenofon
  • Heijde, Désirée van der
  • Sieper, Joachim
  • Inman, Robert Davies
  • Kameda, Hideto
  • Maksymowych, Walter Peter
  • Lagunes-Galindo, Ivan
  • Bu, Xianwei
  • Wung, Peter
  • Kato, Koji
  • Shmagel, Anna
  • Deodhar, Atul
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis

Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis

Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis

Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials

Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials

Relationship between smoking, clinical, inflammatory, and radiographic parameters in patients with ankylosing spondylitis

Relationship between smoking, clinical, inflammatory, and radiographic parameters in patients with ankylosing spondylitis

Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study

Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study

Andersson lesion in ankylosing spondylitis

Andersson lesion in ankylosing spondylitis

Association between changes in serum alkaline phosphatase levels and radiographic progression in ankylosing spondylitis

Association between changes in serum alkaline phosphatase levels and radiographic progression in ankylosing spondylitis

Upadacitinib (ankylosierende Spondylitis) : Nutzenbewertung gemäß § 35a SGB V

Upadacitinib (ankylosierende Spondylitis) : Nutzenbewertung gemäß § 35a SGB V

Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients

Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients

Surgical treatment of ankylosing spondylitis deformity

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

Secukinumab: A Review in Ankylosing Spondylitis

Verbundene Objekte